Tuesday, October 20, 2026 from 8:30 a.m. to 10:00 a.m. MDT at Salt Palace Convention Center - Ballroom G
Available for 1.50 hours of CPE creditActivity Type: A Knowledge-Based ActivityThis comprehensive focus session addresses critical contemporary issues in pharmacy practice across diverse clinical settings. Participants will analyze Medication for Opioid Use Disorder (MOUD) barriers through sophisticated PDMP interpretation and prescriber communication strategies, implementing the PhARM-OUD Guideline's 35 supporting strategies to reduce stigma-driven dispensing obstacles. Participants will then explore Enhanced Recovery After Surgery (ERAS) protocols, equipping pharmacists with practical skills to develop perioperative medication management plans that optimize multimodal analgesia, anticoagulation, and patient outcomes. In these discussions of MOUD barriers and ERAS protocols, pharmacists will examine the role of suzetrigine, the first non-opioid analgesic approved by the FDA in over 25 years, gaining knowledge of its selective Nav1.8 mechanism, pharmacokinetics, drug interactions, and clinical role in acute pain management.
Learning Objectives1. Review the pharmacology and place in therapy of suzetrigine.
2. Define comprehensive perioperative medication management plans utilizing ERAS principles in the preoperative, intraoperative, and postoperative setting.
3. Describe misconceptions and barriers to adequate pain management in acute outpatient surgery patients with MOUD.
4. List implementation strategies for suzetrigine integration, ERAS adoption, and MOUD guideline implementation.
Beyond Stigma: Evaluating Suzetrigine and Evidence-Based MOUD Dispensing to Transform Pain Care for Vulnerable Populations8:30 a.m. to 9:15 a.m. |
The Pharmacist's Perioperative Playbook: Mastering ERAS Protocols and Multimodal Analgesia with Suzetrigine as an Emerging Non-Opioid Consideration9:15 a.m. to 10:00 a.m. |